Company Name SpringLeaf Therapeutics
Mailing Address 8 St. Mary’s Street Boston, MA 02215
Company Description SpringLeaf Therapeutics is creating innovative therapeutic modalities to address serious disease and elevate the quality of care for patients. SpringLeaf’s technology is based on the convergence of materials science and medicine and is designed to enable and differentiate therapeutics.
Proceeds Purposes We have achieved promising preclinical results to date and anticipate clinical testing to initiate in late 2012. With the support of our new and existing investors, SpringLeaf is well positioned to advance our proprietary program, transforming the way patients are treated.